| CAS ID: | 150683-30-0 |
| Molecular Formula: | C26H25ClN2O3 |
| Molecular Weight: | 449 g/mol |
| Monoisotopic Mass: | 448.1554 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | OPC-41061 | SAMSCA | TOLVAPTAN | JINARC |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C26H25ClN2O3/c1-16-6-3-4-7-20(16)25(31)28-19-10-11-21(17(2)14-19)26(32)29-13-5-8-24(30)22-15-18(27)9-12-23(22)29/h3-4,6-7,9-12,14-15,24,30H,5,8,13H2,1-2H3,(H,28,31) | See All |
| InChI Key: | GYHCTFXIZSNGJT-UHFFFAOYSA-N | |
| Smiles: | Cc1ccccc1C(=O)Nc2ccc(C(=O)N3CCCC(O)c4cc(Cl)ccc34)c(C)c2 | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT01114828 | Disease | Liver fibrosis |
| Phase | Phase 3 | Status | Completed |
| First Received | May 3, 2010 | Last Verified | March 4, 2014 |
| Sponsor | Otsuka Pharmaceutical Co., Ltd. | ||
Trial Record 2
| ClinicalTrial ID | NCT01050530 | Disease | Liver fibrosis |
| Phase | Phase 3 | Status | Completed |
| First Received | January 15, 2010 | Last Verified | March 4, 2014 |
| Sponsor | Otsuka Pharmaceutical Co., Ltd. | ||
Trial Record 3
| ClinicalTrial ID | NCT01048788 | Disease | Liver fibrosis |
| Phase | Phase 3 | Status | Completed |
| First Received | January 14, 2010 | Last Verified | April 11, 2016 |
| Sponsor | Otsuka Pharmaceutical Co., Ltd. | ||
Trial Record 4
| ClinicalTrial ID | NCT00479336 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | May 28, 2007 | Last Verified | March 14, 2014 |
| Sponsor | Otsuka Pharmaceutical Co., Ltd. | ||
Trial Record 5
| ClinicalTrial ID | NCT02173288 | Disease | Liver fibrosis |
| Phase | Phase 2,Phase 3 | Status | Completed |
| First Received | June 24, 2014 | Last Verified | September 19, 2017 |
| Sponsor | Postgraduate Institute of Medical Education and Research | ||
Trial Record 6
| ClinicalTrial ID | NCT01359462 | Disease | Liver fibrosis |
| Phase | Phase 1 | Status | Completed |
| First Received | May 24, 2011 | Last Verified | May 24, 2011 |
| Sponsor | Otsuka Beijing Research Institute | ||
Trial Record 7
| ClinicalTrial ID | NCT01349348 | Disease | Liver fibrosis |
| Phase | Phase 3 | Status | Completed |
| First Received | May 6, 2011 | Last Verified | October 12, 2012 |
| Sponsor | Otsuka Beijing Research Institute | ||
Trial Record 8
| ClinicalTrial ID | NCT01349335 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | May 6, 2011 | Last Verified | October 12, 2012 |
| Sponsor | Otsuka Beijing Research Institute | ||
Trial Record 9
| ClinicalTrial ID | NCT01556646 | Disease | Liver fibrosis |
| Phase | Phase 3 | Status | Completed |
| First Received | March 16, 2012 | Last Verified | February 7, 2014 |
| Sponsor | Hunter Holmes Mcguire Veteran Affairs Medical Center | ||
| PubChem: | 216237 |
| ChEMBL: | CHEMBL344159 |